Figure 4 | Scientific Reports

Figure 4

From: In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment

Figure 4

Viability of BEAS-2B cells after treatment with AZM MP (a), RIF MP (b), AZM/RIF MP 1:1 (c), 2:1 (d) and 1:2 (e). Data represent the mean ± S.D. Statistical analysis was performed by one-way and two-way ANOVA with post-hoc Tukey HSD and Bonferroni to determine statistical differences within and among groups. *p < 0.05 vs control; ap < 0.05 vs 0.5 mg/L; bp < 0.05 vs RIF MP.

Back to article page